NCT06338878 PAtient Treatment Analysis: Hospital and Wide-ranging Out-of-hospital Care Assessment Yields Insights Into Heart Failure Outcomes
| NCT ID | NCT06338878 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pr. Nicolas GIRERD |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-03-01 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a monocentric cohort study conducted in the cardiology department of Nancy hospital. The main purpose of the study is to document the global management strategy of patients hospitalized for heart failure and evaluate the association between patient's care and post-hospitalization outcome.
Eligibility Criteria
Inclusion Criteria: * Man or women ≥ 18 years * Patients hospitalized for cardiac decompensation (ESC 2016 and 2021 criteria) Exclusion Criteria: * Patient expressing refusal to participate in research * Patient who is a minor or under administrative protection * Pregnant women * Patient with ventricular assistance * Patient with congenital heart disease
Contact & Investigator
Nicolas GIRERD
STUDY CHAIR
CHRU de Nancy
Frequently Asked Questions
Who can join the NCT06338878 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06338878 currently recruiting?
Yes, NCT06338878 is actively recruiting participants. Contact the research team at l.filippetti@chru-nancy.fr for enrollment information.
Where is the NCT06338878 trial being conducted?
This trial is being conducted at Nancy, France.
Who is sponsoring the NCT06338878 clinical trial?
NCT06338878 is sponsored by Pr. Nicolas GIRERD. The principal investigator is Nicolas GIRERD at CHRU de Nancy. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.